|
Joyce N. LaViscount has served as Chief Accounting Officer and Vice President of Financial Operations at Endo since 2006. She has more than 18 years of experience in the pharmaceutical industry in a variety of finance functions. Prior to joining Endo in April 2004 as the Vice President of Financial Analysis and Planning, Ms. LaViscount served five years at Pharmacia in the Global Commercial Finance Group and the U.S. Consumer Health Care Group as the Director of Financial Planning and Analysis. Before her tenure at Pharmacia, she spent 10 years at Bristol-Myers Squibb in a variety of roles of increasing responsibility in the Worldwide Medicines Group. Prior to joining Bristol-Myers Squibb, Ms. LaViscount spent five years in public accounting at Ernst & Young. | 